GROLUXA Trademark

Trademark Overview

On Wednesday, May 6, 2015, a trademark application was filed for GROLUXA with the United States Patent and Trademark Office. The USPTO has given the GROLUXA trademark a serial number of 79170434. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, July 1, 2022. This trademark is owned by Dompé farmaceutici S.p.A.. The GROLUXA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of eye diseases and conditions; ophthalmologic preparations
groluxa

General Information

Serial Number79170434
Word MarkGROLUXA
Filing DateWednesday, May 6, 2015
Status709 - CANCELLED - SECTION 71
Status DateFriday, July 1, 2022
Registration Number4868950
Registration DateTuesday, December 15, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 29, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of eye diseases and conditions; ophthalmologic preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, July 1, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDOMPE' FARMACEUTICI S.P.A.
Party Type30 - Original Registrant
Legal Entity Type09 - Joint Stock Company
AddressIT
Party NameDompé farmaceutici S.p.A.
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressIT
Party NameDompé farmaceutici S.p.A.
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressIT

Trademark Events

Event DateEvent Description
Tuesday, May 9, 2023TOTAL INVALIDATION PROCESSED BY THE IB
Tuesday, April 18, 2023TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, April 17, 2023INVALIDATION PROCESSED
Wednesday, March 1, 2023TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, July 1, 2022CANCELLED SECTION 71
Friday, June 4, 2021CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, February 12, 2021NEW REPRESENTATIVE AT IB RECEIVED
Thursday, May 19, 2016NOTIFICATION PROCESSED BY IB
Thursday, April 28, 2016NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, February 24, 2016GENERIC MADRID TRANSACTION SENT TO IB
Wednesday, February 24, 2016GENERIC MADRID TRANSACTION CREATED
Thursday, January 14, 2016GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, December 15, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, September 29, 2015PUBLISHED FOR OPPOSITION
Friday, September 25, 2015NOTIFICATION PROCESSED BY IB
Wednesday, September 9, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 9, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 9, 2015NOTICE OF PUBLICATION
Tuesday, August 25, 2015APPLICATION FILING RECEIPT MAILED
Friday, August 21, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 19, 2015ASSIGNED TO EXAMINER
Wednesday, August 19, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 14, 2015LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, August 13, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

groluxa preparations ophthalmologic conditions treatment pharmaceutical diseases